Movatterモバイル変換


[0]ホーム

URL:


US6472144B2 - High throughput screening method and apparatus - Google Patents

High throughput screening method and apparatus
Download PDF

Info

Publication number
US6472144B2
US6472144B2US09/813,922US81392201AUS6472144B2US 6472144 B2US6472144 B2US 6472144B2US 81392201 AUS81392201 AUS 81392201AUS 6472144 B2US6472144 B2US 6472144B2
Authority
US
United States
Prior art keywords
well
cells
voltage
signal
conductance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US09/813,922
Other versions
US20020025575A1 (en
Inventor
Patricia J. Malin
Kenneth R. Wada
Peter J. Dehlinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CellStat Technologies Inc
Original Assignee
CellStat Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CellStat Technologies IncfiledCriticalCellStat Technologies Inc
Priority to US09/813,922priorityCriticalpatent/US6472144B2/en
Publication of US20020025575A1publicationCriticalpatent/US20020025575A1/en
Application grantedgrantedCritical
Priority to US10/284,053prioritypatent/US7354704B2/en
Publication of US6472144B2publicationCriticalpatent/US6472144B2/en
Anticipated expirationlegal-statusCritical
Expired - Fee Relatedlegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

High-throughput screening method and apparatus are described. The method includes placing cells on a substrate defining a plurality of discrete microwells, at a well density of greater than about 100/cm2, with the number of cells in each well being less than about 1000, and where the cells in each well have been exposed to a selected agent. The change in conductance in each well is determined by applying a low-voltage, AC signal across a pair of electrodes paced in that well, and synchronously measuring the conductance across the electrodes, to monitor the level of growth or metabolic activity of cells contained in each well. Also disclosed is an apparatus for carrying out the screening method.

Description

This is a divisional of U.S. application Ser. No. 09/202,658, filed May 14, 1999, now U.S. Pat. No. 6,235,520, which is a 371 of PCT/US97/1121, filed Jun. 26, 1997 and claims the benefit of U.S. application Ser. No. 60/021,074, filed Jun. 27, 1996, which applications are incorporated herein by reference and to which applications priority is claimed under 35 USC § 120 and 119.
FIELD OF THE INVENTION
The present invention relates to high throughput screening (HTS) methods, e.g., for detecting the effect of a given compound or treatment on cell metabolic activity, and apparatus for performing such screening.
BACKGROUND OF THE INVENTION
With the advent of combinatorial library methods for generating large libraries of compounds, there has been a growing interest in high-throughput screening (HTS) methods for screening such libraries.
The most widely used HTS screening method involves competitive or non-competitive binding of library compounds to a selected target protein, such as an antibody or receptor. Thus, for example, to select a library compound capable of blocking the binding of a selected agonist to a receptor protein, the screening method could assay for the ability of library compounds to displace radio-labeled agonist from the target protein.
Although such binding assays can be used to rapidly screen large numbers of compounds for a selected binding activity, the assay itself may have limited relevance to the actual biological activity of the compound in vivo, e.g., its ability to interact with and affect the metabolic behavior of a target cell.
It would therefore be useful to provide high throughput screening methods capable of testing the effects of large numbers of library compounds on target cells of interest.
SUMMARY OF THE INVENTION
The invention includes, in one aspect, high throughput screening apparatus, e.g., for screening the effect of test compound on cell metabolic activity, or for screening the effect of a genetic manipulations on cells. The apparatus includes a multiwell device defining a plurality of discrete microwells on a substrate surface, at a well density of greater than about 100/cm2, where the well volumes are such as to accommodate at most about 106cells/well, preferably between 1-100 wells/cell, and structure for measuring the conductance in each well. The measuring structure includes (i) a pair of electrodes adapted for insertion into a well on the substrate, and (ii) circuitry for applying a low-voltage, AC signal across the electrodes, when the electrodes are submerged in the medium, and for synchronously measuring the current across the electrodes, to monitor the level of growth or metabolic activity of cells contained in the chamber.
In various preferred embodiments, the signal circuitry is effective to generate a signal whose peak-to-peak voltage is between 5 and 10 mV, and includes feedback means for adjusting the signal voltage level to a selected peak-to-peak voltage between 5 and 10 mV.
In other embodiments, the circuitry is designed to sample the voltage of the applied signal at a selected phase angle of the signal, or alternatively, to sample the voltage of the applied signal at a frequency which is at least an order of magnitude greater than that of the signal.
In another general aspect, the invention includes a high-throughput screening method, e.g., for screening the effect of test compounds on cell metabolic activity, or the effect of a given genetic manipulation. The method includes placing cells in the wells of a multiwell device defining a plurality of discrete microwells on a substrate surface, at a well density of greater than about 100/cm2, with the number of cells in each well being less than about 106, and preferably between 1-103. The conductance in each well is determined by applying a low-voltage, AC signal across a pair of electrodes placed in the well, and synchronously measuring the conductance across the electrodes.
These and other objects and features of the invention will become more fully apparent when the following detailed description of the invention is read in conjunction with the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a perspective view of a multiwell device that forms part of the apparatus of the invention;
FIG. 2A is an enlarged, fragmentary cross-sectional view of the device in FIG. 1, with the wells in the device each containing a small number of cells suspended in a culture medium;
FIG. 2B is a view like that in FIG. 2A, but further showing an electrode cover on the device;
FIG. 3 illustrates the grid of conductive wires in the electrode plate shown in FIG. 2B;
FIGS. 4A-4C illustrate another embodiment of the apparatus, here designed for well-by-well conductance measurements;
FIG. 5 shows idealized plots of conductance, as a function of time, in the presence and absence of a library compound that inhibits cell growth or metabolism;
FIG. 6 is a block diagram depicting selected portions of the data acquisition board and of the measurement input/output board in accordance with the present invention; and
FIG. 7 depicts waveforms for the alternating current voltage supplied for application across a pair of pins, an output signal produced by a comparator in response to the alternating current voltage, and a hypothetical output signal from a sample-and-hold amplifier.
DETAILED DESCRIPTION OF THE INVENTION
A. Screening Apparatus and Method
FIG. 1 shows a perspective view of amultiwell device8 formed of asubstrate10 having a plurality of microwells, such aswells12, on the upper substrate surface14. In the embodiment shown, the microwells are formed by a grid of hydrophobic lines, such aslines16 extending lengthwise, andlines18 extending widthwise. The lines are preferably formed of a hydrophobic polymer material, such as polyethylene or polystyrene, and are laid down in a conventional manner, e.g., deposition of melted polymer from an applicator, or heat-mediated attachment of a polymer grid fabric directly to the substrate surface.
Spacing between adjacent parallel lines is preferably 20-200 μm, so that the wells formed by intersecting lines have area dimensions of between about 400 to 40,000 μm2. The density of wells on the substrate is at least 100/cm2and more preferably 103/cm2to 104/cm or greater.
The height (surface relief) of the grid lines, seen best in FIGS. 2B and 2B, is typically between 20-200 μm. Microwell volumes, defined by the volume that can be held as a discrete droplet in a microwell, are typically in therange 10−4to 2 nonoliters.
The microwells in the device may be filled with selected biological cells by applying a suspension of the cells, at a desired cell density, over the device's surface, and allowing excess suspension fluid to drain off, e.g., by blotting the edges of the device. This is illustrated in FIGS. 2A and 2B which show cell suspension droplets, such asdroplet20, in the microwells of the device, such as microwell22. It will be appreciated that the droplet meniscus may extend above the height of the grid lines.
The cell density is adjusted so that the wells are filled, on average, with a selected number of cells which is preferably between 1-100, but may be as high as 103per well. As illustrated in FIGS. 2A and 2B, the density of the cells is such that the device has an average of about 2 cells/well. A greater number of cells/well, e.g., an average of 10-100/well provides improved statistical correlation among events observed in different cells, due to more uniform cell-number distribution in the microwells of the device. At the same time, a small number of cells, e.g., 10-100, allows a microwell (microvolume) format in which desired concentrations of test compounds can be achieved with very small amounts of compound, e.g., in the femptogram to nonogram range. The actual number of cells employed will depend on the particular type of cell and medium, and the confluency requirements of the cells.
With reference particularly to FIG. 2B, the apparatus of the invention, further includes means for measuring the conductance of the cell medium in each well. In the embodiment shown, this means includes amulti-electrode cover27 having a plurality of electrodes pairs, such aselectrode pair26 made up ofelectrodes26a,26bformed as a grid on the lower side of the cover. Specifically, the grid of electrode pairs matches that of microwells indevice8, so that the placement of the cover on the device places an electrode pair in each microwell.
The measuring means also includes asignal unit28 electrically connected to the cover as described below with reference to FIG.3. The operation of the unit to provide a low-voltage AC signal to each electrode, and interrogate the electrode to determine the conductance in each microwell is described below with reference to FIGS. 6 and 7.
FIG. 3 is a plan view ofcover27, showing the grid pattern of conductive wires, such aslongitudinal wires30, andlateral wires32, connecting the electrode pairs in the cover. Each longitudinal wire is connected to an electrode connector, such aswires32 connected toconnectors34, in amulti-connector array36 along one side of the cover, as shown. Similarly, each lateral wire is connected to an electrode connector, such aswires32 connected toconnectors38, in amulti-connector array40 along another side of the cover. The two arrays are designed to plug into matching ports in the signal unit.
As seen in FIG. 2B, each longitudinal wire, such aswire30, is electrically connected to one of the two electrodes in the longitudinal one-dimensional array of electrode pairs, such as thearray including pair26, adjacent the wire. Similarly, each lateral wire, such aswire36, is electrically connected to one of the two electrodes in the lateral one-dimensional array of electrode pairs, such as thearray including pair26, adjacent that wire.
Thus, to interrogate a particular microwell in the device, the signal unit applies a low-voltage signal across the two connectors incover27 which are connected to the two electrodes in that well. For example, to interrogatemicrowell26 in FIG. 2B, the signal unit applies a voltage signal acrossconnectors34,38 connected toelectrodes26a,26b, respectively, forming the electrode pair in that microwell. To this end, the signal unit includes the basic electronics for applying a low-voltage signal to the electrodes, and for synchronously measuring the current across the electrodes, as described below.
Unit28 also includes conventional multiplexing or sampling circuitry for alternately and successively interrogating each microwell, by applying a short duration signal to successively to each well, and measuring the current across the “stimulated” electrodes in accordance with the signalling and current measuring procedures described below. According to one feature of the signal unit, the time required accurately interrogate each microwell can be quite short, on the order of only a few cycles on the applied signal, allowing large arrays to be continuously monitored in real time.
FIGS. 4A-4C illustrate aHTS apparatus42 constructed according to another embodiment of the invention. The apparatus includes amultiwell device44 similar to above describeddevice8, and having a planar array of microwells, such aswells46,48. In this embodiment, however, the measuring means for determining the conductance of each well is carried out by anelectrode arm50 having a pair ofelectrodes52,54 adapted to be received in a selected microwell of the device, and connected to asignal unit56. The electrode arm is movable in the “z” plane between raised and lowered positions in which the electrodes are position above, and in a selected microwell, respectively, as illustrated in FIGS. 4A and 4B, respectively. This movement is produced by a vertical actuator, indicated byarrow58, which is also under the control ofunit50.
Also forming part of the apparatus is a stage60 on which the device is placed during operation. The stage is movable, in an “x-y” plane under the control ofsignal unit56, to alternatively and successively bring each microwell in the device to an interrogation position directly below the electrode arm, as indicated for well46 in FIGS. 4A and 4B. The signal unit also includes the basic electronics for applying a low-voltage signal to the electrodes, and for synchronously measuring the current across the electrodes, as described below.
In an exemplary operation, for use in screening combinatorial library compounds, and with reference particularly to the embodiment shown in FIGS. 1-3, the microwells in the device are filled with a cell suspension, as above, and the library compounds are added to each of wells, either before or after cell addition. For example, using microfabrication techniques of the type described in U.S. Pat. No. 5,143,854, a position-addressable planar array of polymer library molecules is formed on a planar substrate—in this case having or subsequently prepared to have a hydrophobic grid forming the microwells, which correspond to the individual library-polymer regions. After addition of the cells, the library compounds may be released for interaction with the cells, e.g., by inclusion in the cell suspension of an enzyme capable of cleaving the library molecules from the substrate surface.
Alternatively, the library compounds may be contained on a grid of pins or the like corresponding to the microwell grid, allowing the compounds to be simultaneously introduced into the wells, and released into the corresponding wells, e.g., by enzymatic cleavage of a linker.
Alternatively, the library compounds may be distributed well-by-well into the microwell device, either as single compounds or mixtures of library compounds.
After introducing the compound to be tested, the microwells are interrogated to determine the conductance of medium in each cell, by measuring the current across the electrodes. In the present example, it is assumed that (i) a large number of individual library compounds are added to the device, one per well, and (ii) one or more of the compounds is able to inhibit metabolic activity and/or replication of the cells. In the absence of any inhibition, cell metabolism and growth will occur normally, leading to an increase in measured conductance over time, as illustrated byplot number1 in FIG.5. Since only a few of the test compounds will be expected to have an inhibitory effect, most or nearly all of the plots will be represented by the “normal” plot.
Where an inhibitory compound is present, this will be evidenced by a lower rate of conductance change over time, as indicated bycurves2 and3 in FIG. 5, wherecurve2 represents moderate inhibition, and curve3, nearly complete inhibition. The reduced conductance may be due to reduced metabolism and/or reduced replication. To confirm the latter possibility, the microwells of interest may be further examined for cell count, using standard cell counting methods.
In another general embodiment, the screening method is employed to monitor the success of a selected genetic manipulation, e.g., transformation of the cells with a selected vector, treatment with a transforming virus such as EBV, or cell fusion. In this embodiment, the genetically manipulated cells are distributed on the microwell device as above, and changes in cell conductance, related to cell replication are monitored. Those wells that show significant increase in cell conductance over time are then selected as cells which are successfully manipulated. Thus, for example, if the cells are transformed with a vector containing a selectable antibiotic marker gene, cells which grow in the presence of the antibiotic can be readily identified by the increased conductance in the corresponding microwell(s).
B. Signal Unit Construction and Operation
FIG. 6 is a block diagram in accordance with one preferred embodiment of the present invention depicting a portion of the electronic circuit for applying the potential across a pair of pins orelectrodes26a,26b, and for monitoring the current across the pins.
A computer program executed by a computer system included in the cell culture monitoring and recording system causes aprogrammable gain amplifier70 included in adata acquisition board72 to transmit a voltage representative of that applied across a pair ofpins26a,26binserted into a well for digitization by a measurement input/output board74. The measurement input/output board74 of the present embodiment is preferably a MetraByte DAS-8 Data Acquisition and Control Board marketed by Keithley Metrabyte Corporation of Taunton, Mass.
To supply the alternating current voltage that is applied across a selected pair ofpins26a,26b, thedata acquisition board72 includes aprogrammable voltage source76. Theprogrammable voltage source76 includes an alternatingcurrent generator78 that produces a 370 Hz ±20%, 10 volt peak-to-peak sine wave signal. The output signal produced by the alternatingcurrent generator78 is transmitted to aprogrammable attenuator80 also included in theprogrammable voltage source76. Digital excitation level control signals supplied from the computer system to theprogrammable attenuator80 via excitation levelcontrol signal lines82 permit adjustment of the peak-to-peak voltage supplied to afirst terminal84 of a resistor, such as a 20.04K ohm resistor86.
Asecond terminal88 of theresistor86 connects to a bank ofswitches90. One of theswitches90 is selected by the computer system for applying the alternating current voltage supplied by theprogrammable voltage source76 to a pair ofpins26a,26bthat extend into the well being monitored.
The AC voltage applied across a pair ofpins26a,26bis also supplied to the input of theprogrammable gain amplifier70. The gain of theamplifier70 may be adjusted by control signals supplied from the computer system via gain control signal lines92. The output signals from theprogrammable attenuator80, and from theprogrammable gain amplifier70 are both supplied tomultiplexer94. Control signals supplied from the computer system to multiplexer94 via multiplexercontrol signal lines96 select one of these three signals for application to an input of a sample-and-hold amplifier100 included in the measurement input/output board74.
The output signal from the sample-and-hold amplifier100 is supplied to the input of an analog-to-digital converter102 also included in the measurement input/output board74. In addition to being supplied to theprogrammable attenuator80, the 10 volt peak-to-peak output signal from the alternatingcurrent generator78 is also supplied to the input of acomparator104. The output signal from thecomparator104 changes state each time the alternating current voltage produced by the alternatingcurrent generator78 passes through zero volts.
Thus, while the alternating current voltage produced by thegenerator78 has a potential greater than zero volts, the output signal from thecomparator104 is in one state, and while that voltage has a potential less than zero volts, the output signal from thecomparator104 is in its other state. The output signal from thecomparator104 is supplied to aprogrammable timer106 included in the measurement input/output board74.
As described herein, the voltage present at thesecond terminal88 ofresistor86 is applied across the two pins of a selected well12 via aswitch90. This “pin voltage”, which is proportional to the conductivity of the medium and the current flow between the two pins, is measured by theprogrammable gain amplifier70. To efficiently obtain a reliable measurement of this voltage (and of the underlying current), the pin voltage is preferably sampled synchronously with the applied voltage. This can be done in several ways, two of which are described below.
1. Sampling at a selected phase angle.
FIG. 7 depicts a sinusoidal alternatingcurrent waveform110 for the voltage present at the output of the alternatingcurrent generator78 together with the adigital waveform112 of the output signal produced by thecomparator104. During initialization of the cell culture monitoring and recording system and at any subsequent time that it is requested by an operator of the cell culture monitoring and recording system, the computer program executed by the computer system executes a procedure for establishing a delay period (“D”) of a selected duration that is shorter than one cycle of thesine waveform110. For example, in FIG. 7, the delay period begins when thesine waveform110 is changing from a positive potential to a negative potential has a potential of zero volts, and ends when thesine waveform110 has its immediately subsequent maximum positive value.
In measuring the delay period D, the computer program uses the output signal from thecomparator104 in thedata acquisition board72 together with theprogrammable timer106 included in the measurement input/output board74 to determine the duration of one period of thesine waveform110. The computer program then establishes the delay period D at three-fourths of one period of thesine waveform110. Having determined a proper delay period D, the computer program then loads that delay period into theprogrammable timer106 so that all subsequent measurements of the electrical potential across a pair ofpins26a,26bwill occur when the voltage supplied to thefirst terminal84 of theresistor86 reaches its maximum value, i.e., at the same selected phase angle of each cycle.
In measuring the voltage applied across a pair ofpins26a,26b, theprogrammable timer106 begins measuring each delay period at the instant at which thesine waveform110 is changing from a positive potential to a negative potential has a potential of zero volts, i.e. immediately after the digital value of the output signal from thecomparator104 supplied to theprogrammable timer106 changes from 0 to 1. When the delay period D expires, theprogrammable timer106 causes the sample-and-hold amplifier100 to sample and hold the voltage of the signal supplied from the output of theprogrammable gain amplifier70 via themultiplexer94 as illustrated in thewaveform114 depicted in FIG.7.
Theprogrammable timer106 also causes the analog-to-digital converter102 to convert the voltage of the analog signal received from the sample-and-hold amplifier100 into a digital form. Subsequently, this digital number is transferred from the measurement input/output board74 to the computer system for storage as raw data suitable for subsequent analysis and graphic display.
2. Sampling at a frequency which is at least an order of magnitude greater than the applied voltage.
Another way of synchronously sampling the pin voltage, which is proportional to the current across the electrodes, is to sample and digitize the signal at a frequency which is at least an order of magnitude greater than the applied voltage (termed “burst sampling”). In this mode of operation, the pin voltage is sampled an digitized a selected number of times (e.g., 10-1000) during a single cycle of the applied voltage. This can be accomplished, for example, by triggering the beginning and of storage of a string of digitized current values with the rising or falling transition of thedigital waveform112 of the output signal produced by thecomparator104. Such a digitized waveform can be analyzed with respect to the applied voltage using the computer system to calculate, for example, any phase lead or lag of the underlying current with respect to the applied voltage, as well as the peak-to-peak and/or RMS current values. These current values can in turn be used in the calculation of the conductance of the medium as described herein. An advantage of this approach is that an accurate estimate of the conductance can be obtained in a single cycle of the applied voltage, enabling rapid multiplex sampling of a plurality of samples.
Adjusting Voltage Applied Across a Pair of Pins.
In addition to performing the above, the program executed by the computer system also determines the alternating current voltage to be applied from thesecond terminal88 of theresistor86 across the pair ofpins26a,26bduring such monitoring. To determine this alternating current voltage, the computer program first adjusts theprogrammable attenuator80 so a potential of approximately 10 millivolts is present at its output and at thefirst terminal84 of theresistor86. Because the 20.04 K ohm resistance of theresistor86 separates its first terminal84 from itssecond terminal88, and because any cell growth media held in the well12 provides some electrical conductivity between the pair ofpins26a,26binserted therein, initially the voltage at thesecond terminal88 and across a pair ofpin26a,26bmust be less than the value of 10 millivolts intended to be used in measuring the conductivity between a pair ofpins26a,26b. The computer program then causes themultiplexer94 to select the output signal from theprogrammable gain amplifier70 for application to the input of the sample-and-hold amplifier100, sets the gain of theprogrammable amplifier70 so a peak voltage of 120 millivolts at thesecond terminal88 of theresistor86 will result in the analog-to-digital converter102 producing a digital number that is approximately 83.3% of the full range of the analog-to-digital converter102, and causes the bank ofswitches90 to select a pair ofpins26a,26bfor application of the alternating. current voltage.
The cell culture monitoring and recording system then measures the peak alternating current voltage present at thesecond terminal88 of theresistor86 that is applied across the pair ofpins26a,26b. If the voltage at thesecond terminal88 and across the pair ofpins26a,26bis less than 5 millivolts, the computer program doubles the alternating current voltage produced by theprogrammable attenuator80 repeatedly until the voltage measured at thesecond terminal88 exceeds 5 millivolts. Having thus applied and measured an alternating current voltage across the pair ofpins26a,26bthat exceeds 5 millivolts and knowing the setting for theprogrammable attenuator80 which produces that voltage, the computer program then computes a new setting for theprogrammable attenuator80 that will apply approximately a 10 millivolt alternating current voltage to thesecond terminal88 and across the pair ofpins26a,26b, and then transmits control signals setting theattenuator80 to the computed value.
Having established the value for the alternating currant voltage applied by theprogrammable attenuator80 to thefirst terminal84 of theresistor86, the system is now prepared to monitor and record the electrical conductivity of the well12. In measuring the conductivity of the well12, the computer program first repetitively measures the voltage applied across the pair ofpins26a,26band at thesecond terminal88 of theresistor86. For example, applying the method of measuring at a selected phase angle, the computer system collects16 successive values for this voltage, and the computer program then computes an average of the 16 values using a box-car filter to obtain a single, average value for the voltage across the pair ofpins26a,26b. Alternatively, applying the burst sampling approach, a single, average value can be obtained from the RMS value of the digitized signal. Using the single value of the pin voltage, the value of the voltage supplied by theprogrammable attenuator80 to thefirst terminal84 of theresistor86, and the resistance of theresistor86; the computer program then computes the conductivity of the cell growth media and cells, if any, between the pair ofpins26a,26b.
Having determined the conductivity between the pair ofpins26a,26bfor this well12, the computer program first stores the conductivity value for subsequent analysis and then proceeds to measure the conductivity between another pair ofpins26a,26bextending into another well12 in themicrowell device8. In determining the conductivity of each well, the cell culture monitoring and recording system uses the procedures set forth above of first adjusting the alternating current voltage applied across the pair ofpins26a,26b, and then measuring and averaging the voltage applied across the pair ofpins26a,26bextending into thewell12. This adjusting of the applied voltage and determining of cell conductivity is repeated over and over until a conductivity has been determined and stored for allwells12 in themicrowell device8.
At least one of thewells12 in themicrowell device8 is preferably a reference well that holds only cell culture media without cells. Furthermore, this reference well must be specifically so identified to the analysis computer program because that program uses the conductivity value for the reference well in analyzing the conductivity for all the other wells.
Analysis of the conductivity of a well that held both cell growth media and cells included dividing the conductivity measured for the reference well by the conductivity measured for the well that held both the cell growth media and cells. Rather than using the electrical conductivity of the reference well as the numerator of a fraction analyzing the conductivity of a well that holds both cell growth media and cells, it has been found more advantageous in analyzing the conductivity of wells holding both cell growth media and cells to subtract the conductivity determined for the reference well from the conductivity determined for the well holding both cell growth media and cells. Subtracting the conductivity measured for the reference well, i.e. a well that holds only cell growth media without cells, from the conductivity measured for wells that holds both growth media and cells removes the electrical conductivity of the cell growth media from the data for such wells. Removing the cell growth media conductivity from the data for the well results in data values for the wells holding both cell growth media and cells that more closely represents the electrical conductivity of only the cells themselves, and the cells' metabolic products.
While the preferred embodiments of the present invention as described above employ a sinusoidal alternating current in monitoring cell cultures, it may be possible to employ any periodic voltage waveform that is symmetric about zero volts in determining conductivity between a pair ofpins26a,26b. Thus, for example, a system for monitoring and recording cell cultures in accordance with the present invention could employ an alternating current voltage having a triangular waveform.
Since a triangular waveform alternating current voltage may be easily generated using a digital logic circuit, in a system employing such a waveform it would be unnecessary to directly measure, as described above, the delay period D. Rather the digital circuits used in generating the triangular waveform alternating current voltage could themselves directly produce signals for controlling the operation of the sample-and-hold amplifier100 and the analog-to-digital converter102. However, such a system for monitoring and recording cell cultures would merely employ a different, well know technique for determining the delay period for its alternating current voltage that i is equal to an interval of time between the alternating current voltage having an instantaneous potential of zero volts and having an instantaneous potential equal to the maximum voltage of the alternating current voltage.
Although the invention has been described with respect to particular embodiments and features, it will be appreciated that various changes and modifications can be made without departing from the invention. As an example, and in another preferred embodiment, the probes are inserted into the well from the bottom of the well to allow for easy serialization of the unit and minimal media volume.

Claims (5)

What is claimed:
1. A high throughput screening method comprising
placing cells on a substrate defining a plurality of discrete microwells on a substrate surface, at a well density of greater than about 100/cm2, with the number of cells in each well being less than about 103,
where the cells in each well have been exposed to a selected agent, and
determining the conductance in each well, by applying a low-voltage, AC signal across a pair of electrodes placed in that well, and synchronously measuring the conductance across the electrodes, to monitor the level of growth or metabolic activity of cells contained in each well.
2. The method ofclaim 1, wherein the signal applied across the electrodes is between 5 and 10 mV.
3. The method ofclaim 1, wherein said measuring includes measuring the conductance in the medium at a selected phase angle of the signal.
4. The method ofclaim 1, wherein said measuring is designed to measure the conductance of the medium at a measuring frequency which is at least an order of magnitude greater than that of said signal.
5. The method ofclaim 1, wherein the wells contain at most 10-100 cells.
US09/813,9221996-06-272001-03-20High throughput screening method and apparatusExpired - Fee RelatedUS6472144B2 (en)

Priority Applications (2)

Application NumberPriority DateFiling DateTitle
US09/813,922US6472144B2 (en)1996-06-272001-03-20High throughput screening method and apparatus
US10/284,053US7354704B2 (en)1996-06-272002-10-29High throughout screening method and apparatus

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US2107496P1996-06-271996-06-27
US09/202,658US6235520B1 (en)1996-06-271997-06-26High-throughput screening method and apparatus
US09/813,922US6472144B2 (en)1996-06-272001-03-20High throughput screening method and apparatus

Related Parent Applications (3)

Application NumberTitlePriority DateFiling Date
US09/202,658DivisionUS6235520B1 (en)1996-06-271997-06-26High-throughput screening method and apparatus
PCT/US1997/011211DivisionWO1997049987A1 (en)1996-06-271997-06-26High-throughput screening method and apparatus
US09202658Division1997-06-26

Related Child Applications (1)

Application NumberTitlePriority DateFiling Date
US10/284,053ContinuationUS7354704B2 (en)1996-06-272002-10-29High throughout screening method and apparatus

Publications (2)

Publication NumberPublication Date
US20020025575A1 US20020025575A1 (en)2002-02-28
US6472144B2true US6472144B2 (en)2002-10-29

Family

ID=21802195

Family Applications (3)

Application NumberTitlePriority DateFiling Date
US09/202,658Expired - Fee RelatedUS6235520B1 (en)1996-06-271997-06-26High-throughput screening method and apparatus
US09/813,922Expired - Fee RelatedUS6472144B2 (en)1996-06-272001-03-20High throughput screening method and apparatus
US10/284,053Expired - Fee RelatedUS7354704B2 (en)1996-06-272002-10-29High throughout screening method and apparatus

Family Applications Before (1)

Application NumberTitlePriority DateFiling Date
US09/202,658Expired - Fee RelatedUS6235520B1 (en)1996-06-271997-06-26High-throughput screening method and apparatus

Family Applications After (1)

Application NumberTitlePriority DateFiling Date
US10/284,053Expired - Fee RelatedUS7354704B2 (en)1996-06-272002-10-29High throughout screening method and apparatus

Country Status (5)

CountryLink
US (3)US6235520B1 (en)
EP (1)EP0950184A1 (en)
AU (1)AU3508197A (en)
CA (1)CA2258279A1 (en)
WO (1)WO1997049987A1 (en)

Cited By (26)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20030219824A1 (en)*1996-06-272003-11-27Cellstat Technologies, Inc.High throughput screening method and apparatus
US20040152067A1 (en)*2002-07-202004-08-05Xiaobo WangImpedance based apparatuses and methods for analyzing cells and particles
US20050112544A1 (en)*2002-12-202005-05-26Xiao XuImpedance based devices and methods for use in assays
US20050153425A1 (en)*2002-12-202005-07-14Xiao XuReal time electronic cell sensing systems and applications for cell-based assays
US20050213374A1 (en)*2002-12-202005-09-29Xiao XuReal time electronic cell sensing system and applications for cytoxicity profiling and compound assays
US20050221282A1 (en)*1998-06-122005-10-06Cenes LimitedHigh throughput screen
US20060023559A1 (en)*2002-12-202006-02-02Xiao XuMethod for assaying for natural killer, cytotoxic T-lymphocyte and neutrophil-mediated killing of target cells using real-time microelectronic cell sensing technology
US20060050596A1 (en)*2002-12-202006-03-09Abassi Yama ADynamic monitoring of activation of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology
US20060120204A1 (en)*2002-12-202006-06-08Abassi Yama ADynamic monitoring of cell adhesion and spreading using the RT-CES system
WO2006102445A1 (en)*2005-03-222006-09-28Cellstat Technologies, Inc.Method for profiling cells using conductance data
US20080124703A1 (en)*2006-09-202008-05-29Xiaobo WangUse of impedance-based cytological profiling to classify cellular response profiles upon exposure to biologically active agents
US20120058467A1 (en)*2007-12-052012-03-08Ge Healthcare Uk LimitedApparatus and method for detecting dna damage
US8206903B2 (en)2002-12-202012-06-26Acea BiosciencesDevice and method for electroporation-based delivery of molecules into cells and dynamic monitoring of cell responses
WO2015097560A2 (en)2013-12-232015-07-02Basf SeMethods for determining modulators of insect transient receptor potential v (trpv) channel
US9447135B2 (en)2012-12-142016-09-20University Of Kentucky Research FoundationSemi-synthetic mithramycin derivatives with anti-cancer activity
US9612234B2 (en)2008-05-052017-04-04Acea Biosciences, Inc.Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (RTCA) cardio instruments
US9709548B2 (en)2008-05-052017-07-18Acea Biosciences, Inc.Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution
WO2019023559A1 (en)2017-07-272019-01-31University Of Southern CaliforniaOtopetrin proton channels as targets for pharmaceutical discovery
US10215748B2 (en)2002-12-202019-02-26Acea Biosciences, Inc.Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways
US10539523B2 (en)2002-12-202020-01-21Acea Biosciences, Inc.System and method for monitoring cardiomyocyte beating, viability, morphology, and electrophysiological properties
US10551371B2 (en)2003-11-102020-02-04Acea Biosciences, Inc.System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function
USD941488S1 (en)2020-02-072022-01-18Agilent Technologies, Inc.Instrument for analyzing biological cells
US11346797B2 (en)2002-12-202022-05-31Agilent Technologies, Inc.System and method for monitoring cardiomyocyte beating, viability, morphology and electrophysiological properties
US11746328B2 (en)2017-03-032023-09-05Agilent Technologies, Inc.Methods and systems for functional maturation of iPSC and ESC derived cardiomyocytes
US12049615B2 (en)2020-03-292024-07-30Agilent Technologies, Inc.Systems and methods for electronically and optically monitoring biological samples
US12066428B2 (en)2015-11-202024-08-20Agilent Technologies, Inc.Cell-substrate impedance monitoring of cancer cells

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6391578B2 (en)1997-04-092002-05-213M Innovative Properties CompanyMethod and devices for partitioning biological sample liquids into microvolumes
US6696286B1 (en)1997-04-092004-02-243M Innovative Properties CompanyMethod and devices for detecting and enumerating microorganisms
BRPI9810844B1 (en)*1997-08-012016-04-05Minnesota Mining & Mfg test device for detecting microorganisms in a liquid sample, and process for conducting a more likely number of analyzes
US20020144905A1 (en)1997-12-172002-10-10Christian SchmidtSample positioning and analysis system
US7244349B2 (en)1997-12-172007-07-17Molecular Devices CorporationMultiaperture sample positioning and analysis system
EP1040349B2 (en)1997-12-172012-12-19Ecole Polytechnique Federale De Lausanne (Epfl)Positioning and electrophysiological characterization of individual cells and reconstituted membrane systems on microstructured carriers
EP0955084B1 (en)1998-04-272006-07-26Corning IncorporatedMethod of depositing an array of biological samples using a redrawn capillary reservoir
US6884626B1 (en)1998-04-272005-04-26Corning IncorporatedRedrawn capillary imaging reservoir
US6350618B1 (en)1998-04-272002-02-26Corning IncorporatedRedrawn capillary imaging reservoir
US6762061B1 (en)1998-07-032004-07-13Corning IncorporatedRedrawn capillary imaging reservoir
US6542858B1 (en)1998-09-142003-04-01Lion Bioscience AgPharmacokinetic-based drug design tool and method
FR2789401B1 (en)*1999-02-082003-04-04Cis Bio Int METHOD FOR MANUFACTURING LIGAND DIES ADDRESSED ON A MEDIUM
US6174699B1 (en)1999-03-092001-01-163M Innovative Properties CompanyDisc assay device with inoculation pad and methods of use
CA2388982A1 (en)*1999-11-052001-05-10Novozymes A/SMicrotiter plate (mtp) based high throughput screening (hts) assays
GR1003489B (en)*1999-11-192000-11-30Method for the determination of biological and chemical compounds by measuring changes in the electrical properties of immobilized cells or cell components (bioelectric recognition assay)
GB9930718D0 (en)*1999-12-242000-02-16Central Research Lab LtdApparatus for and method of making electrical measurements on objects
GB9930719D0 (en)*1999-12-242000-02-16Central Research Lab LtdApparatus for and method of making electrical measurements on an object in a m edium
WO2001094666A2 (en)*2000-06-082001-12-13Ylektra Inc.Spatially addressable electrolysis platform and methods of use
US20020025514A1 (en)*2000-07-052002-02-28Jaworski Deborah D.High throughput assay
US7270730B2 (en)2000-08-042007-09-18Essen Instruments, Inc.High-throughput electrophysiological measurement system
US7067046B2 (en)*2000-08-042006-06-27Essen Instruments, Inc.System for rapid chemical activation in high-throughput electrophysiological measurements
US6783735B2 (en)*2000-09-152004-08-31Agfa-GevaertWeb material having wells for combinatorial applications
WO2003050524A1 (en)*2001-05-232003-06-19Spiridon KintziosMethod for identifying biochemical material
US6649402B2 (en)*2001-06-222003-11-18Wisconsin Alumni Research FoundationMicrofabricated microbial growth assay method and apparatus
DE60227094D1 (en)*2001-10-152008-07-24Biocept IncMicrowell-biochip
US6949347B2 (en)*2002-03-052005-09-27Aclara Biosciences, Inc.Multiplex analysis using membrane-bound sensitizers
US7232547B2 (en)*2002-03-222007-06-19Marshfield ClinicApparatus and method for testing and continuously reading low-volume samples
US7279585B2 (en)*2002-07-262007-10-09Monogram Biosciences, Inc.Lipophilic electrophoretic probes
AU2003296994A1 (en)*2002-12-132004-07-09Applera CorporationMethods for identifying, viewing, and analyzing syntenic and orthologous genomic regions between two or more species
JP2007526438A (en)*2003-06-062007-09-13コンビナトルックス インコーポレイテッド System and method for multidimensional evaluation of composition combinations
US20050038776A1 (en)*2003-08-152005-02-17Ramin CyrusInformation system for biological and life sciences research
US8277760B2 (en)*2003-09-192012-10-02Applied Biosystems, LlcHigh density plate filler
US20050232821A1 (en)*2003-09-192005-10-20Carrillo Albert LHigh density plate filler
US20070014694A1 (en)*2003-09-192007-01-18Beard Nigel PHigh density plate filler
US20050221357A1 (en)*2003-09-192005-10-06Mark ShannonNormalization of gene expression data
US20060233671A1 (en)*2003-09-192006-10-19Beard Nigel PHigh density plate filler
US7407630B2 (en)*2003-09-192008-08-05Applera CorporationHigh density plate filler
US20050220675A1 (en)*2003-09-192005-10-06Reed Mark THigh density plate filler
US7998435B2 (en)2003-09-192011-08-16Life Technologies CorporationHigh density plate filler
US20060233673A1 (en)*2003-09-192006-10-19Beard Nigel PHigh density plate filler
US20060272738A1 (en)*2003-09-192006-12-07Gary LimHigh density plate filler
US20050226782A1 (en)*2003-09-192005-10-13Reed Mark THigh density plate filler
US7332280B2 (en)*2003-10-142008-02-19Ronald LevyClassification of patients having diffuse large B-cell lymphoma based upon gene expression
EP2639576B1 (en)*2004-02-092016-04-20ACEA Biosciences, Inc.Real-time electronic cell sensing system and applications for cytotoxicity profiling and compound assays
US7501301B2 (en)*2004-03-102009-03-10The Board Of Trustees Of The Leland Stanford Junior UniversityLow cost fabrication of microelectrode arrays for cell-based biosensors and drug discovery methods
US20060111915A1 (en)*2004-11-232006-05-25Applera CorporationHypothesis generation
CA2595452A1 (en)*2005-01-262006-08-03Rapid Laboratory Microsystems Inc.Method, system and device for obtaining electrochemical measurements
JP2010516281A (en)2007-01-222010-05-20ウェハージェン,インコーポレイテッド High-throughput chemical reaction equipment
US20090205780A1 (en)*2008-02-182009-08-20International Business Machine CorporationBonding pad for electronic subassemblies
US9534206B2 (en)2010-12-162017-01-03General Electric CompanyCell carrier, associated methods for making cell carrier and culturing cells using the same
US9926523B2 (en)2010-12-162018-03-27General Electric CompanyCell carriers and methods for culturing cells
US9453196B2 (en)2010-12-162016-09-27General Electric CompanyCell carrier, methods of making and use
US9518249B2 (en)2010-12-162016-12-13General Electric CompanyCell carrier, associated methods for making cell carrier and culturing cells using the same
US20120156777A1 (en)*2010-12-162012-06-21General Electric CompanyCell carrier, associated methods for making cell carrier and culturing cells using the same
US9453197B2 (en)2010-12-162016-09-27General Electric CompanyMethods of making cell carrier
CN109781630A (en)*2013-01-042019-05-21梅索磅秤技术有限公司Assay device, method and reagent
ES2915663T3 (en)*2014-01-162022-06-24Hamamatsu Photonics Kk Cell observation device, electrical stimulation device and cell observation method
EP3259602B9 (en)2015-02-202021-05-19Takara Bio USA, Inc.Method for rapid accurate dispensing, visualization and analysis of single cells
US10533966B2 (en)2017-07-272020-01-14Taiwan Semiconductor Manufacturing Co., Ltd.Digital time domain readout circuit for bioFET sensor cascades
US11846626B2 (en)2017-11-092023-12-19Battelle Savannah River Alliance, LlcElectrochemical detection of microbial stress
CN110187091B (en)*2019-04-182020-11-27浙江大学 A high-throughput 3D cell impedance sensor and detection method for antitumor drug screening
US12098993B2 (en)*2020-12-082024-09-24Tdk CorporationDevices and methods for determining impedance of single biological cells

Citations (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5643742A (en)*1990-04-031997-07-01Cellstat Technologies, Inc.System for electronically monitoring and recording cell cultures
WO1997049987A1 (en)*1996-06-271997-12-31Cellstat Technologies, Inc.High-throughput screening method and apparatus

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB1585067A (en)1976-10-191981-02-25Nat Res DevDetection of bacterial activity
US4156180A (en)*1977-06-241979-05-22Bactomatic, Inc.Apparatus and method for detecting metabolic activity
US5066372A (en)*1986-05-021991-11-19Ciba Corning Diagnostics Corp.Unitary multiple electrode sensor
US5218312A (en)1988-07-201993-06-08Ricardo MoroMeasurement apparatus for measuring a biological substance within a fluid substrate
GB8927377D0 (en)*1989-12-041990-01-31Univ EdinburghImprovements in and relating to amperometric assays
CA2079897A1 (en)*1990-04-031991-10-04Patricia J. MalinElectronic technique of identifying an effective drug for treating a cancer patient
WO1994003583A1 (en)*1992-07-291994-02-17OncotherapeuticsAn improved system for electronically monitoring and recording cell cultures
US5605662A (en)*1993-11-011997-02-25Nanogen, Inc.Active programmable electronic devices for molecular biological analysis and diagnostics
US5846708A (en)*1991-11-191998-12-08Massachusetts Institiute Of TechnologyOptical and electrical methods and apparatus for molecule detection
US5218662A (en)*1992-05-061993-06-08Alcatel Network Systems, Inc.Fiber-optic cable system and method for dispersion compensation at nodes between end points
US5432086A (en)*1992-11-181995-07-11Sy-Lab Vertriebsgellschaft M.B.H.Apparatus for the automatic monitoring of microorganism culture
US5810725A (en)*1993-04-161998-09-22Matsushita Electric Industrial Co., Ltd.Planar electrode
US5650061A (en)*1995-09-181997-07-22The Regents Of The University Of CaliforniaLarge amplitude sinusoidal voltammetry

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5643742A (en)*1990-04-031997-07-01Cellstat Technologies, Inc.System for electronically monitoring and recording cell cultures
WO1997049987A1 (en)*1996-06-271997-12-31Cellstat Technologies, Inc.High-throughput screening method and apparatus
US6235520B1 (en)*1996-06-272001-05-22Cellstat Technologies, Inc.High-throughput screening method and apparatus

Cited By (60)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US7354704B2 (en)*1996-06-272008-04-08Cellstat Technologies, Inc.High throughout screening method and apparatus
US20030219824A1 (en)*1996-06-272003-11-27Cellstat Technologies, Inc.High throughput screening method and apparatus
US10006902B2 (en)1998-06-122018-06-26Sophion Bioscience A/SHigh throughput screen
US20050221282A1 (en)*1998-06-122005-10-06Cenes LimitedHigh throughput screen
US8759017B2 (en)1998-06-122014-06-24Xention LimitedHigh throughput screen
US8449825B2 (en)1998-06-122013-05-28Xention LimitedHigh throughput screen
US7846389B2 (en)1998-06-122010-12-07Xention LimitedHigh throughput screen
US20040152067A1 (en)*2002-07-202004-08-05Xiaobo WangImpedance based apparatuses and methods for analyzing cells and particles
US10067121B2 (en)2002-07-202018-09-04Acea Biosciences, Inc.Dynamic monitoring of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) activity and pathways in living cells using real-time microelectronic cell sensing technology
US8921041B2 (en)2002-07-202014-12-30Acea Biosciences, Inc.Device and method for electroporation-based delivery of molecules into cells and dynamic monitoring of cell responses
US7459303B2 (en)2002-07-202008-12-02Acea BiosciencesImpedance based apparatuses and methods for analyzing cells and particles
US7468255B2 (en)2002-12-202008-12-23Acea BiosciencesMethod for assaying for natural killer, cytotoxic T-lymphocyte and neutrophil-mediated killing of target cells using real-time microelectronic cell sensing technology
US8344742B2 (en)2002-12-202013-01-01Acea Biosciences, Inc.Real time electronic cell sensing system and applications for cytotoxicity profiling and compound assays
US7192752B2 (en)2002-12-202007-03-20Acea BiosciencesReal time electronic cell sensing systems and applications for cell-based assays
US11604197B2 (en)2002-12-202023-03-14Agilent Technologies, Inc.Real time electronic cell sensing systems and applications for cell-based assays
US10168318B2 (en)2002-12-202019-01-01Acea Biosciences, Inc.Method of measuring cell-substrate impedance in living cells to identify compounds affecting receptor tyrosine kinase (RTK) activity and pathways
US20050112544A1 (en)*2002-12-202005-05-26Xiao XuImpedance based devices and methods for use in assays
US7470533B2 (en)2002-12-202008-12-30Acea BiosciencesImpedance based devices and methods for use in assays
US7560269B2 (en)2002-12-202009-07-14Acea Biosciences, Inc.Real time electronic cell sensing system and applications for cytotoxicity profiling and compound assays
US20090309618A1 (en)*2002-12-202009-12-17Xiao XuReal Time Electronic Cell Sensing System and Applications For Cytotoxicity Profiling and Compound Assays
US7732127B2 (en)2002-12-202010-06-08Acea Biosciences, Inc.Dynamic monitoring of cell adhesion and spreading using the RT-CES system
US20060120204A1 (en)*2002-12-202006-06-08Abassi Yama ADynamic monitoring of cell adhesion and spreading using the RT-CES system
US7876108B2 (en)2002-12-202011-01-25Acea Biosciences, Inc.Real time electronic cell sensing system and applications for cytotoxicity profiling and compound assays
US8026080B2 (en)2002-12-202011-09-27Acea Biosciences, Inc.Real time electronic cell sensing system and applications for cell-based assays
US20070172939A1 (en)*2002-12-202007-07-26Xiao XuReal time electronic cell sensing system and applications for cell-based assays
US11346797B2 (en)2002-12-202022-05-31Agilent Technologies, Inc.System and method for monitoring cardiomyocyte beating, viability, morphology and electrophysiological properties
US8206903B2 (en)2002-12-202012-06-26Acea BiosciencesDevice and method for electroporation-based delivery of molecules into cells and dynamic monitoring of cell responses
US8263375B2 (en)2002-12-202012-09-11Acea BiosciencesDynamic monitoring of activation of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology
US10215748B2 (en)2002-12-202019-02-26Acea Biosciences, Inc.Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways
US20060050596A1 (en)*2002-12-202006-03-09Abassi Yama ADynamic monitoring of activation of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology
US20060023559A1 (en)*2002-12-202006-02-02Xiao XuMethod for assaying for natural killer, cytotoxic T-lymphocyte and neutrophil-mediated killing of target cells using real-time microelectronic cell sensing technology
US8916357B2 (en)2002-12-202014-12-23Acea Biosciences, Inc.Dynamic monitoring of activation of receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology
US20050213374A1 (en)*2002-12-202005-09-29Xiao XuReal time electronic cell sensing system and applications for cytoxicity profiling and compound assays
US10725023B2 (en)2002-12-202020-07-28Acea Biosciences, Inc.Method of measuring cell-substrate impedance in living cells to identify compounds affecting receptor tyrosine kinase (RTK) activity and pathways for the treatment of cancer
US9399787B2 (en)2002-12-202016-07-26Acea Biosciences, Inc.Real-time electronic cell sensing system and applications for cytotoxicity profiling and compound assays
US10690677B2 (en)2002-12-202020-06-23Acea Biosciences, Inc.Real time electronic cell sensing systems and applications for cell-based assays
US10620188B2 (en)2002-12-202020-04-14Acea Biosciences, Inc.Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways
US9625472B2 (en)2002-12-202017-04-18Acea Biosciences, Inc.Real time electronic cell sensing systems and applications for cell-based assays
US10018581B2 (en)2002-12-202018-07-10Acea Biosciences, Inc.Impedance based devices and methods for use in assays
US20050153425A1 (en)*2002-12-202005-07-14Xiao XuReal time electronic cell sensing systems and applications for cell-based assays
US10539523B2 (en)2002-12-202020-01-21Acea Biosciences, Inc.System and method for monitoring cardiomyocyte beating, viability, morphology, and electrophysiological properties
US10551371B2 (en)2003-11-102020-02-04Acea Biosciences, Inc.System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function
WO2006102445A1 (en)*2005-03-222006-09-28Cellstat Technologies, Inc.Method for profiling cells using conductance data
US20060256599A1 (en)*2005-03-222006-11-16Malin Patricia JDatabase of electronically profiled cells and methods for generating and using same
US8041515B2 (en)2006-09-202011-10-18Acea Biosciences, Inc.Use of impedance-based cytological profiling to classify cellular response profiles upon exposure to biologically active agents
US20080124703A1 (en)*2006-09-202008-05-29Xiaobo WangUse of impedance-based cytological profiling to classify cellular response profiles upon exposure to biologically active agents
US20120058467A1 (en)*2007-12-052012-03-08Ge Healthcare Uk LimitedApparatus and method for detecting dna damage
US11360072B2 (en)2008-05-052022-06-14Agilent Technologies, Inc.Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution
US9709548B2 (en)2008-05-052017-07-18Acea Biosciences, Inc.Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution
US9612234B2 (en)2008-05-052017-04-04Acea Biosciences, Inc.Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (RTCA) cardio instruments
US10012636B2 (en)2008-05-052018-07-03Acea Biosciences, Inc.Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution
US10533985B2 (en)2008-05-052020-01-14Acea Biosciences, IncLabel-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution
US11906508B2 (en)2008-05-052024-02-20Agilent Technologies, Inc.Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution
US9447135B2 (en)2012-12-142016-09-20University Of Kentucky Research FoundationSemi-synthetic mithramycin derivatives with anti-cancer activity
WO2015097560A2 (en)2013-12-232015-07-02Basf SeMethods for determining modulators of insect transient receptor potential v (trpv) channel
US12066428B2 (en)2015-11-202024-08-20Agilent Technologies, Inc.Cell-substrate impedance monitoring of cancer cells
US11746328B2 (en)2017-03-032023-09-05Agilent Technologies, Inc.Methods and systems for functional maturation of iPSC and ESC derived cardiomyocytes
WO2019023559A1 (en)2017-07-272019-01-31University Of Southern CaliforniaOtopetrin proton channels as targets for pharmaceutical discovery
USD941488S1 (en)2020-02-072022-01-18Agilent Technologies, Inc.Instrument for analyzing biological cells
US12049615B2 (en)2020-03-292024-07-30Agilent Technologies, Inc.Systems and methods for electronically and optically monitoring biological samples

Also Published As

Publication numberPublication date
EP0950184A1 (en)1999-10-20
US20030219824A1 (en)2003-11-27
US20020025575A1 (en)2002-02-28
WO1997049987A1 (en)1997-12-31
US7354704B2 (en)2008-04-08
EP0950184A4 (en)1999-10-20
US6235520B1 (en)2001-05-22
AU3508197A (en)1998-01-14
CA2258279A1 (en)1997-12-31

Similar Documents

PublicationPublication DateTitle
US6472144B2 (en)High throughput screening method and apparatus
US11906508B2 (en)Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution
US5643742A (en)System for electronically monitoring and recording cell cultures
US10539523B2 (en)System and method for monitoring cardiomyocyte beating, viability, morphology, and electrophysiological properties
US10551371B2 (en)System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function
US20250297982A1 (en)Electronic circuits for analyzing electrogenic cells and related methods
US20050231186A1 (en)High throughput electrophysiology system
WO2001007583A1 (en)Cell/tissue analysis via controlled electroporation
WO2010129725A1 (en)System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function
EP3435076A1 (en)Electrochemical measurement method, electrochemical measurement apparatus, and transducer
CA2140892A1 (en)An improved system for electronically monitoring and recording cell cultures
US11346797B2 (en)System and method for monitoring cardiomyocyte beating, viability, morphology and electrophysiological properties
Borkholder et al.An approach to the classification of unknown biological agents with cell based sensors
WO2006130990A2 (en)Detecting electrical activity and assessing agents for the ability to influence electrical activity in neuronal cell networks
EP0655086B1 (en)An improved system for electronically monitoring and recording cell cultures
EP1405919B1 (en)A method for electronically monitoring and recording cell cultures
EP4513179A1 (en)Impedance measurement apparatus and impedance measurement method
AU766011B2 (en)Detection of potential acid sulphate soils
WO1999064852A1 (en)Detection of potential acid sulphate soils
HK1065071A1 (en)A method for electronically monitoring and recording cell cultures
HK1065071B (en)A method for electronically monitoring and recording cell cultures
Hofer et al.The effect of interelectrode distances on measurements of the local potential gradient of the propagating cardiac excitation at a microscopic size scale

Legal Events

DateCodeTitleDescription
FPAYFee payment

Year of fee payment:4

REMIMaintenance fee reminder mailed
LAPSLapse for failure to pay maintenance fees
STCHInformation on status: patent discontinuation

Free format text:PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FPLapsed due to failure to pay maintenance fee

Effective date:20101029


[8]ページ先頭

©2009-2025 Movatter.jp